Mendel, a San Jose, CA-based provider of a clinical artificial intelligence and natural language processing platform, raised $40M in Series B funding.
Oak HC/FT was the leader of the round, with participation from DCM.
The company plans to use the funds for its AI and engineering team expansions, scaling the commercial organization, and accelerating the release of Resolve, its product that consolidates clinical data to provide a consistent longitudinal view of the patient’s journey.
Mendel, which is headed by CEO Karim Gail, can read and understand medical information. It utilizes AI technology to read and understand medical literature, as well as patient records. This allows for a variety of Real-World Data applications.